At the conclusion of the activity, learners will be able to:
1) Prescribe postmenopausal hormone therapy to appropriate candidates
2) List risks/benefits of EPT vs ET
3) Describe the differences between different formulations/routes of delivery of E and P
4) Inform your patients about the differences between FDA-approved and compounded BHT
Professional practice gap that will be addressed: Hormone therapy use has declined dramatically since the release of the results of the Women’s Health Initiative study in 2002. As the number of women entering menopause continues to increase, the number of providers needed to care for these women is also increasing. Internists and family medicine specialists are uniquely qualified to prescribe and manage hormone therapy as they are trained to evaluate and integrate the factors impacting the multiple organ systems affected by menopause. Improving the competencies of these specialists in the management of menopausal symptoms is critical to address this gap.
Target audience: Physicians, mid-level providers, nurses